Literature DB >> 20569089

Pharmacotherapy of prostatitis.

Devon C Snow1, Daniel A Shoskes.   

Abstract

IMPORTANCE OF THE FIELD: Prostatitis is a prevalent and morbid condition with a significant impact on a patient's quality of life. The four distinct prostatitis syndromes have different pathophysiologies, therapy and prognosis. Acute and chronic bacterial prostatitis is best treated with appropriate antibiotics that penetrate the prostate and kill the causative organisms. The most challenging category to treat is category III or chronic prostatitis/chronic pelvic pain syndrome. AREAS COVERED IN THE REVIEW: This review covers the categories of prostatitis and currently recommended therapies, as well as novel approaches on the horizon. WHAT THE READER WILL GAIN: Knowledge of the current framework for the diagnosis and management of the diverse prostatitis spectrum. TAKE HOME MESSAGE: Prostatitis is a diverse group of syndromes. Chronic prostatitis/chronic pelvic pain syndrome is a multifactorial syndrome that requires a multimodal approach to effectively treat the patient. The UPOINT technique is used to clinically phenotype these patients and drive the selection of multimodal therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569089     DOI: 10.1517/14656566.2010.495946

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada.

Authors:  J Curtis Nickel; Dean Tripp; Allan Gordon; Michel Pontari; Daniel Shoskes; Kenneth M Peters; Ragi Doggweiler; Andrew Paul Baranowski
Journal:  Rev Urol       Date:  2011

2.  A host defense mechanism involving CFTR-mediated bicarbonate secretion in bacterial prostatitis.

Authors:  Chen Xie; Xiaoxiao Tang; Wenming Xu; Ruiying Diao; Zhiming Cai; Hsiao Chang Chan
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

3.  Effect of thermophilic bacterium HB27 manganese superoxide dismutase in a rat model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  Nai-Wen Chen; Jing Jin; Hong Xu; Xue-Cheng Wei; Ling-Feng Wu; Wen-Hua Xie; Yu-Xiang Cheng; Yi He; Jin-Lai Gao
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

4.  Comparison of 3 assessment modes of acupuncture effect on patients with chronic prostatitis/chronic pelvic pain syndrome: A study protocol for a randomized controlled trial.

Authors:  Jing Zhou; Yan Liu; Chunbin Li; Zhishun Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.